Treatment For Alzheimer's Disease And Related Conditions
申请人:Pineiro Jose Luis Castro
公开号:US20080051403A1
公开(公告)日:2008-02-28
This invention provides the combination of a growth hormone secretagogue and a p38 kinase inhibitor for use in treatment or prevention of a disease associated with deposition of Aβ in the brain.
[EN] COMBINATION OF GH SECRETAGOGUES AND PDE4 INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE<br/>[FR] THÉRAPIE COMBINÉE DESTINÉE À LA MALADIE D'ALZHEIMER
申请人:MERCK SHARP & DOHME
公开号:WO2004087157A2
公开(公告)日:2004-10-14
There is disclosed the treatment or prevention of diseases involving deposition of beta-amyloid in the brain, e.g. Alzheimer's disease, via the combined administration of a growth hormone secretagogue and a PDE4 inhibitor.
[EN] TREATMENT FOR ALZHEIMER'S DISEASE AND RELATED CONDITIONS<br/>[FR] TRAITEMENT DE LA MALADIE D'ALZHEIMER ET DE PATHOLOGIES ASSOCIEES
申请人:MERCK SHARP & DOHME
公开号:WO2004110443A1
公开(公告)日:2004-12-23
There is disclosed the combination of a growth hormone secretagogue and at least one agent which modifies the production or processing of Aβ in the brain, said at least one agent being selected from: (a) compounds which inhibit the secretion of Aβ; (b) compounds which selectively inhibit the secretion of the 1-42 isoform of Aβ; (c) compounds which inhibit the aggregation of Aβ; and (d) antibodies which selectively bind to Aβ; for use in treatment or prevention of a disease associated with deposition of Aβ in the brain.